期刊文献+

盐酸安他唑啉在大鼠体内的药动学研究 被引量:1

Determination of antazoline hydrochloride in rat plasma by HPLC and its application to pharmacokinetic study
原文传递
导出
摘要 目的:建立高效液相色谱分析法评价灌胃给予盐酸安他唑啉在大鼠体内的药动学特征。方法:采用HPLC-内标法,液液萃取SD大鼠血浆中的待测物和内标物,以C18柱将待测物分离,用可变波长紫外检测器进行检测。流动相为甲醇-5mmol·L-1四丁基溴化铵(40:60);流速为1.0ml·min。结果:盐酸安他唑啉在50-4000ng·ml-1范围内线性关系良好(R〉0.9993),定量下限达到50ng·ml-1。日内和日间精密度值均小于15%。准确度在89.9%-110.6%的范围内。盐酸安他唑啉的样品绝对回收率大于80%,非那西汀的绝对回收率在75%以上。灌胃后其主要动力学参数:AUG0-1=(5.15±0.39)mg·h·L-1、AUC=(5.37±0.26)mg·h·L-1、z1/2=(3.91±0.88)h、CL=(1.86±0.09)L·kg-1·h-1、V=(8.07±2.51)L·kg-1、c=(3.35±0.21)mg·L-1、tmax=(0.75±0.36)h。结论:该方法准确度高、灵敏度强,可用于大鼠灌胃给药盐酸安他唑啉后体内药物动力学研究。结果盐酸安他唑啉在大鼠体内消除快,不易蓄积,为其临床药动学以及生物等效性研究提供了理论依据。 OBJECTIVE To establish a HPLC method for the determination of antazoline hydrochloride in rat plasma and to study the pharmacokinetics of antazoline hydrochloride in rats. METHODS A sensitive and specific HPLC method was developed and validated using phenacetin as the internal standard (IS). The analyte and the IS were extracted from rat by ethyl acetate under the basic condition. The analytes were separated by a C18 column and detected with a variable wavelength UV-detector. The mobile phase consisted of methanol-5 mmol L-1 tetrabutyl ammonium bromide (40:60) and the flow rate was 1.0 ml · min- 7 RESULTS Standard calibration graph for antazoline hydrochloride was linear over a curve range of 50 - 4 000 ng. ml- 1 (R= 0. 999 3) and the lower limit of quantification was 50 ng.m1-1 using a plasma sample of 100μ1. The intra- and inter-day precision values were less than 13.30% relative standard deviation (RSD). The intra-day and inter-day assay precision was in the range of + 15%and the accuracy in the range of 89. 9%- 110. 6%. The extraction recoveries were on the average of 80% for antazoline hydroehloride and 75% for IS. After i. g. administration of antazoline hydroehloride, the major pharmacokinetic parameters were as follows:AUGht = (5.15 + 0. 39) mg.h.L-1 , AUC = (5.37 ±0. 26) mg.h-L-1 , t1/2 = (3.91 ± 0. 88) h, CL=(1.86±0.09) L.kg-1,h-1,V=(8.07±2.51) L-kg -1, C = (3. 35 ± 0. 21) mg-L-1 , tmax = (0. 75 ± 0. 36) h. CX)NCLUSION This method was successfully applied to pharmacokinetic studies of antazoline hydrochloride after ig administration to SD rats.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2014年第17期1456-1459,共4页 Chinese Journal of Hospital Pharmacy
关键词 盐酸安他唑啉 SD大鼠 高效液相色谱法 药物代谢动力学 antazoline hydrochloride RP-HPLC SD rat pharmacokinetics
  • 相关文献

参考文献10

  • 1Leonard S Dreifus, Thomas F McGarry, Yoshio Watanabe S, et al. Clinical and physiologie effects of antazoline, a new anti- arrhythmic agent[J]. Am J Heart, 1963, 65: 607-614.
  • 2Reynolds EW Jr, Baird WM, Clifford ME. A clinical trial of antazoline in the treatment of arrhythmias[J]. Am J Cardiol, 1964, 14: 513-521.
  • 3Farkowski MM, Maciag A, Dabrowski R, et al. Clinical effi- cacy of antazoline in rapid cardioversion of paroxysmal atrial fi- brillation a protocol of a single center, randomized, double- blind, placebo-controlled study (the AnPAF Study) [J]. Tri- als, 2012,13: 162.
  • 4王靖,楚建民,贾玉和,毛克修,陈旭华,陶燕,华伟,张澍.盐酸安他唑啉片治疗室性早搏的随机、双盲、阳性药对照研究[J].中国分子心脏病学杂志,2010,10(5):281-284. 被引量:3
  • 5Yousry M, Issa, Hosny Ibrahim, Adel F, Shoukry, Sabry K, et al. Indirect Atomic Absorption and Atomic Emission Spec- trometric Determination of Antazoline, Hydralazine and Amiloride Hydrochlorides and Quinine Sulphate [J]. Mikro- chim Acta, 1995, 118: 257-263.
  • 6邱颖姮,周敏贤,李玉兰.反相高效液相色谱法测定盐酸安他唑啉片的含量[J].中国药业,2009,18(1):26-27. 被引量:1
  • 7.中国药典二部[S].,2005年版.68.
  • 8Wang R, Chu Y, Li X, et al. Determination of antazoline hydrochloride in rat plasma and excreta by reversed phase ion- pair chromatography and its application to pharmacokinetics [J]. Biomed Chromatogr,2013,27(12) : 1595-1602.
  • 9Li X, Chu Y, Ke Y, etal. Determination of antazoline hydro- chloride in Beagle dog plasma by HPLC-UV and its application to pharraacokinetics[J] J Chromatogr B Analyt Technol Bi- omed Life Sci, 2013,929: 97-101. doi: 10. 1016/j. jchromb. 2013.04. 021.
  • 10李好枝.体内药物分析[M].北京:中国医药科技出版社,2001:354-356

二级参考文献13

  • 1李青,朱兆仪,向菊兰.联合应用胺碘酮及安他唑啉治疗阵发性心房颤动及维持窦性心律的疗效观察(摘要)[J].中国循环杂志,1996,11(7):430-430. 被引量:5
  • 2曹克将,陈椿.抗心律失常药物的应用进展[J].中国实用内科杂志,2007,27(1):14-17. 被引量:90
  • 3Le(o)n-Sotomayor L:A clinical evaluation of the antiarrhythmic properties of antazoline.Am J Cardiol 1963,11(5):646-653.
  • 4Reynolds EW,Baird WM,Clifford ME:A clinical trial of antazoline in the treatment of arrhythmias.Am J Cardiol 1964,14(4):513-521.
  • 5The cardiac arrhythmia suppression trial-Ⅱ investigators.Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction:the Cardiac Arrhythmia Suppression Trial-Ⅱ.N Engl J Med.1992; 327(4):227-233.
  • 6Durra NK:Some pharmacologic properties common to antihistamine compounds.Br J Pharmacol 1949,4(3):281-289.
  • 7McKechnie JK:Cardiac action of antihistamine compounds; review of literature and preliminary case report.S Afr Med J 1952,26(3).609-612.
  • 8Dreifus LS,McGrarry TF Watanabe Y,et al:Clinical and physioiogic effects of antazoline,a new antiarrhythmic agent.Am Heart J 1963,65(5):607-614.
  • 9Shah SS,Vaidya CH,Doshi HV.Antazoline in the treatment of cardiac arrhythmias.Postgraduate Medical Journal,1972,48(559),304-307.
  • 10ACHRISTIANSEN 1,NISSEN NI,THOMSEN C.Antazoline in cardiac arrhythmias.Nord Med.1965; 73(1):315-317.

共引文献102

同被引文献12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部